Peripheral Artery Disease and Venous Thromboembolic Events After Acute Coronary Syndrome: Role of Lipoprotein(a) and Modification by Alirocumab: Prespecified Analysis of the ODYSSEY OUTCOMES Randomized Clinical Trial.

There was a nonsignificant trend toward an association of PAD events with the baseline level of LDL-C corrected , a parameter that estimates the cholesterol contained in low-density lipoprotein particles by algebraic correction for the cholesterol contained in lipoprotein(a), but ordinarily measured as LDL-C.

also in 5,406 other papers